Surinder Kaur

7.7k citations

93 papers · 3.9k indexed · h-index 37

Impact in

Applied Psychology top 2%
- Digital Mental Health Interventions
Oncology top 2%
- HER2/EGFR in Cancer Research
- Cytokine Signaling Pathways and Interactions

Papers in ⓘ

Molecular Biology 41
- PI3K/AKT/mTOR signaling in cancer 18
- Protein purification and stability 9
Oncology 41
- HER2/EGFR in Cancer Research 19
- Cytokine Signaling Pathways and Interactions 17

Co-authors: Leonidas C. Platanias (21 shared papers)Keyang Xu (17 shared papers)Ola M. Saad (12 shared papers)Antonella Sassano (11 shared papers)David Keßler (3 shared papers)Eleanor N. Fish (10 shared papers)Randall Dere (6 shared papers)Beata Majchrzak-Kita (6 shared papers)
Journals: Bioanalysis (14 papers)Journal of Biological Chemistry (7 papers)Analytical Chemistry (6 papers)Proceedings of the National Academy of Sciences (4 papers)mAbs (3 papers)
Partner nations: United States Canada India

In The Last Decade

Surinder Kaur

90 papers receiving 3.7k citations

Peers

Countries citing papers authored by Surinder Kaur

Since Specialization

Citations

This map shows the geographic impact of Surinder Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Surinder Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Surinder Kaur more than expected).

Fields of papers citing papers by Surinder Kaur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Surinder Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Surinder Kaur. The network helps show where Surinder Kaur may publish in the future.

Co-authors

The 25 scholars most cited alongside Surinder Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Surinder Kaur Line = papers co-authored together Surinder Kaur links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial The Lancet ·David Keßler, Glyn Lewis, Surinder Kaur, Nicola Wiles, Michael King, Scott Weich, Debbie Sharp, Ricardo Araya, Sandra Hollinghurst, T. J. Peters	2009	278
2	Role of the Akt pathway in mRNA translation of interferon-stimulated genes Proceedings of the National Academy of Sciences ·Surinder Kaur, Antonella Sassano, Blazej Dolniak, Sonali Joshi, Beata Majchrzak-Kita, Darren P. Baker, Nissim Hay, Eleanor N. Fish, Leonidas C. Platanias	2008	171
3	Bioanalytical Assay Strategies for The Development of Antibody–Drug Conjugate Biotherapeutics Bioanalysis ·Surinder Kaur, Keyang Xu, Ola M. Saad, Randall Dere, Montserrat Carrasco‐Triguero	2013	157
4	Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats Bioconjugate Chemistry ·C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang, Daniela Bumbaca, Nicole Valle, Katherine R. Kozak, Aimee Fourie, Josefa Chuh, Neelima Koppada, Ola M. Saad, Herman Gill, Ben‐Quan Shen, Bonnee Rubinfeld, Jay Tibbitts, Surinder Kaur, Frank‐Peter Theil, Paul J. Fielder, Leslie A. Khawli, Kedan Lin	2011	155
5	Critical roles for mTORC2- and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells Proceedings of the National Academy of Sciences ·Nathalie Carayol, Eliza Vakana, Antonella Sassano, Surinder Kaur, Dennis J. Goussetis, Heather Glaser, Brian Druker, Nicholas J. Donato, Jessica K. Altman, Sharon Barr, Leonidas C. Platanias	2010	145
6	Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein Biotherapeutics The AAPS Journal ·Rand Jenkins, Jeffrey X. Duggan, Anne‐Françoise Aubry, Jianing Zeng, Jean W. Lee, Laura Cojocaru, Dawn Dufield, Fabio Garofolo, Surinder Kaur, Gary A. Schultz, Keyang Xu, Ziping Yang, John S. Yu, Yan J Zhang, Faye Vazvaei	2014	140
7	Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability Toxicology and Applied Pharmacology ·Kirsten Achilles Poon, Kelly M. Flagella, Joseph C. Beyer, Jay Tibbitts, Surinder Kaur, Ola M. Saad, Joo-Hee Yi, Sandhya Girish, Noël Dybdal, Theresa Reynolds	2013	140
8	Primary‐care patients’ expectations and experiences of online cognitive behavioural therapy for depression: a qualitative study Health Expectations ·Angela Beattie, Alison Shaw, Surinder Kaur, David Keßler	2009	134
9	Characterization of intact antibody–drug conjugates from plasma/serum in vivo by affinity capture capillary liquid chromatography–mass spectrometry Analytical Biochemistry ·Keyang Xu, Luna Liu, Ola M. Saad, Jakub Baudys, Lara Williams, Douglas D. Leipold, Ben Shen, Helga Raab, Jagath R. Junutula, Amy Kim, Surinder Kaur	2011	122
10	Bioanalysis of Antibody–Drug Conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group Position Paper Bioanalysis ·Boris Gorovits, Stephen C. Alley, Sanela Bilic, Brian Booth, Surinder Kaur, Phillip Oldfield, Shobha Purushothama, Chetana Rao, Stacy S. Shord, Patricia Siguenza	2013	108
11	Identification of longitudinally dynamic biomarkers in Alzheimer’s disease cerebrospinal fluid by targeted proteomics Molecular Neurodegeneration ·Kristin R. Wildsmith, Stephen Schauer, Ashley M. Smith, David Arnott, Yuda Zhu, Joshua Haznedar, Surinder Kaur, W. Rodney Mathews, Lee Honigberg	2014	100
12	Cost-effectiveness of therapist-delivered online cognitive–behavioural therapy for depression: randomised controlled trial The British Journal of Psychiatry ·Sandra Hollinghurst, T. J. Peters, Surinder Kaur, Nicola Wiles, Glyn Lewis, David Keßler	2010	96
13	Regulatory Effects of Mammalian Target of Rapamycin-activated Pathways in Type I and II Interferon Signaling Journal of Biological Chemistry ·Surinder Kaur, Lakhvir Lal, Antonella Sassano, Beata Majchrzak-Kita, Maya Srikanth, Darren P. Baker, Emmanuel Petroulakis, Nissim Hay, Nahum Sonenberg, Eleanor N. Fish, Leonidas C. Platanias	2006	92
14	Catabolic Fate and Pharmacokinetic Characterization of Trastuzumab Emtansine (T-DM1): an Emphasis on Preclinical and Clinical Catabolism Current Drug Metabolism ·Ben‐Quan Shen, Daniela Bumbaca, Ola M. Saad, Qin Yue, Cinthia V. Pastuskovas, S. Cyrus Khojasteh, Jay Tibbitts, Surinder Kaur, Bei Wang, Yu‐Waye Chu, Patricia LoRusso, Sandhya Girish	2012	92
15	Dual mTORC2/mTORC1 Targeting Results in Potent Suppressive Effects on Acute Myeloid Leukemia (AML) Progenitors Clinical Cancer Research ·Jessica K. Altman, Antonella Sassano, Surinder Kaur, Heather Glaser, Barbara Kroczyńska, Amanda J. Redig, Suzanne Russo, Sharon Barr, Leonidas C. Platanias	2011	85
16	The Granulin/Epithelin Precursor Abrogates the Requirement for the Insulin-like Growth Factor 1 Receptor for Growth in Vitro Journal of Biological Chemistry ·Shiqiong Xu, Dazhi Tang, Scott Chamberlain, Gijsbertus J. Pronk, Frank R. Masiarz, Surinder Kaur, Marco di Prisco, Tommaso Zanocco‐Marani, Renato Baserga	1998	81
17	Characterization of The Drug-To-Antibody Ratio Distribution for Antibody–Drug Conjugates in Plasma/Serum Bioanalysis ·Keyang Xu, Luna Liu, Randall Dere, Elaine Mai, Rebecca Erickson, Angela Hendricks, Kedan Lin, Jagath R. Junutula, Surinder Kaur	2013	79
18	Dual Regulatory Roles of Phosphatidylinositol 3-Kinase in IFN Signaling The Journal of Immunology ·Surinder Kaur, Antonella Sassano, Ajith M. Joseph, Beata Majchrzak-Kita, Elizabeth A. Eklund, Amit Verma, Saskia M. Brachmann, Eleanor N. Fish, Leonidas C. Platanias	2008	76
19	The PI3' Kinase Pathway in Interferon Signaling Journal of Interferon & Cytokine Research ·Surinder Kaur, Shahab Uddin, Leonidas C. Platanias	2005	67
20	Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses Proceedings of the National Academy of Sciences ·Sonali Joshi, Surinder Kaur, Amanda J. Redig, Katy Goldsborough, Kevin A. David, Takeshi Ueda, Rie Watanabe‐Fukunaga, Darren P. Baker, Eleanor N. Fish, Rikiro Fukunaga, Leonidas C. Platanias	2009	63

About Surinder Kaur

Surinder Kaur is a scholar working on Molecular Biology, Oncology, Immunology, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 93 papers that have together received 3.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), HER2/EGFR in Cancer Research (19 papers), PI3K/AKT/mTOR signaling in cancer (18 papers), Cytokine Signaling Pathways and Interactions (17 papers), Biosimilars and Bioanalytical Methods (15 papers), Protein purification and stability (9 papers), interferon and immune responses (8 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Applied Psychology (327 citations), Oncology (1.4k citations), Immunology (1.1k citations), Radiology, Nuclear Medicine and Imaging (1.1k citations) and Molecular Biology (1.6k citations). Surinder Kaur has collaborated with scholars based in United States, Canada and India. Frequent co-authors include Leonidas C. Platanias, Keyang Xu, Ola M. Saad, Antonella Sassano, David Keßler, Eleanor N. Fish, Randall Dere, Beata Majchrzak-Kita, Sandra Hollinghurst and Montserrat Carrasco‐Triguero. Their work appears in journals such as Bioanalysis, Journal of Biological Chemistry, Analytical Chemistry, Proceedings of the National Academy of Sciences and mAbs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact